Home/CVE/Unspecified vulnerability in the PD tools component in IBM WebSphere Application Server (WAS) 6.1.0.7 and earlier has un
CVE

CVE-2007-3264

Unspecified vulnerability in the PD tools component in IBM WebSphere Application Server (WAS) 6.1.0.7 and earlier has un

Unspecified vulnerability in the PD tools component in IBM WebSphere Application Server (WAS) 6.1.0.7 and earlier has unknown impact and attack vectors.

HIGH · CVSS 10 EPSS 0.01044
Schedule remediation
  • CVSS base score ≥ 7.0
Sigma rules0 YARA rules0
▤

Affected Products & Versions

1
ibm websphere application server<= 6.1.0.7
▣

Scoring & Timeline

10
HIGH · CVSS v2 (legacy) · cve@mitre.org
View on NVD
This CVE predates CVSS v3; the legacy v2 score is shown so triage still has a severity to work with.
v2 Vector
AV:N/AC:L/Au:N/C:C/I:C/A:C
Published to NVD19 Jun 2007 · 06:30 PM
🔗

References & Sources

6
Source URLs (vendor pages, mailing lists, write-ups). Exploit/PoC links are in their own section above to avoid duplication.
http://osvdb.org/41611
http://secunia.com/advisories/25704PatchVendor Advisory
http://www-1.ibm.com/support/docview.wss?uid=swg27007951Patch
http://www.securityfocus.com/bid/24505
http://www.vupen.com/english/advisories/2007/2234
https://exchange.xforce.ibmcloud.com/vulnerabilities/34904
Intelligence Graph · click any node to traverse
CVETechnique ActorTool Family
drag to reposition · click any node to traverse · button top-right enlarges
External lookups - second-class, for what we don’t hold ourselves
NVDCVE.orgCISAVulnersExploit-DBGitHub PoCVulnCheck KEVGreyNoise
Vulnerabilities
CISA KEV catalog
CWE weaknesses
CAPEC attack patterns
Package vulnerabilities
Threat intelligence
Threat actors
Tools & malware
ATT&CK techniques
IOCs
Detection & defense
Sigma rules
YARA rules
Atomic Red Team tests
D3FEND countermeasures
Compliance
NIST 800-53
ISO 27001:2022
SOC 2 TSC
PCI-DSS v4.0
CIS Controls v8.1
About
All capabilities
Live statistics
Data sources
Privacy policy
Terms of service
threatengine.sh  ·  Open-source threat intelligence platform  ·  100+ authoritative sources  ·  Every fact traces to its origin